ExxonMobil Continues to Show That It's the Best Oil Stock
Exxon reported sector-leading earnings in the second quarter.
The company also returned more cash to investors than its peers and ended the quarter with the industry's best balance sheet.
Exxon expects to maintain its leadership position in the coming years.
10 stocks we like better than ExxonMobil ›
ExxonMobil (NYSE: XOM) is in a class of its own. The oil company recently reported its second-quarter financial results, which led the sector across most key categories.
The company is in an excellent position to continue delivering leading results going forward, making it a compelling oil stock to buy and hold for the long term.
Drilling down into Exxon's second-quarter financial results
ExxonMobil earned $7.1 billion and generated $11.5 billion in cash flow from operations in the second quarter. That led all international oil companies (IOCs) by a wide margin. Exxon's earnings were more than double Chevron 's ($3.1 billion) and well ahead of Shell 's ($4.3 billion).
"The second quarter, once again, proved the value of our strategy and competitive advantages, which continue to deliver for our shareholders no matter the market conditions or geopolitical developments," stated CEO Darren Woods in the second-quarter earnings release. The oil giant delivered its highest second-quarter production total since the merger of Exxon and Mobil more than a quarter century ago at 4.6 million barrels of oil equivalent (BOE) per day.
Its output rose 13%, fueled mainly by its acquisition of Pioneer Natural Resources. Additionally, Exxon reported the best quarter yet for high-value product sales in its products solution segment.
Another factor fueling Exxon's strong financial results is its structural cost savings program. The company has delivered $1.4 billion of savings this year, increasing its total to $13.5 billion since 2019. That's more than all other IOCs combined.
Exxon's strong cash flows enabled it to return an industry-leading $9.2 billion to its shareholders in the second quarter through dividends and share repurchases, leading the oil sector. It's on track to buy back $20 billion of its stock this year. Since May 2024, Exxon has already purchased about 40% of the shares it issued to buy Pioneer Natural Resources. Even with those lofty cash returns, Exxon maintained its sector-leading balance sheet featuring the industry's lowest leverage ratio, at 8% net debt to capital.
Even better days lie ahead for the oil giant
Exxon has commenced operations on six key projects this year and expects to start up four more by year-end. "Collectively, these projects are expected to improve our earnings power by more than $3 billion in 2026 at constant prices and margins," commented CEO Darren Woods in the second-quarter earnings press release.
Those projects are only the beginning. Exxon's plan to 2030 has it on pace to invest $140 billion in major capital projects and its Permian Basin development program over the next five years. Exxon also aims to deliver a total of $18 billion in structural cost savings by the end of 2030.
The company estimates that this plan will provide it with incremental growth potential of $20 billion in earnings and $30 billion in cash flow by 2030. That positions it to deliver compound annual growth rates of 10% for earnings and 8% for cash flow over the next several years.
The oil giant's plan would produce a staggering $165 billion in cumulative surplus cash over the next five years. That will provide Exxon with ample funds to continue increasing its dividend (a sector-leading 42 consecutive years) and repurchasing a substantial amount of stock. (It plans to repurchase $20 billion annually in 2025 and 2026.)
The best-performing oil stock
ExxonMobil is the undisputed leader in the oil sector, as evidenced by its industry-leading financial results in the second quarter. This allowed it to return more cash to investors than peers while maintaining the sector's top balance sheet.
The oil giant isn't likely to give up its leadership position anytime soon. Its plan up to 2030 would see it deliver meaningful earnings and cash flow growth over the next few years, allowing it to continue returning lots of money to investors. That combination of growth and cash returns positions Exxon to continue delivering peer-leading total return, which it has done over the past five years with its impressive 25% compound annual total return.
Should you invest $1,000 in ExxonMobil right now?
Before you buy stock in ExxonMobil, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and ExxonMobil wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!*
Now, it's worth noting Stock Advisor's total average return is 1,019% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 29, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
7 minutes ago
- Globe and Mail
DMC Global (BOOM) Q2 Revenue Beats Views
Key Points DMC Global (NASDAQ:BOOM) exceeded analyst expectations for both non-GAAP earnings per share and GAAP revenue in Q2 2025. Year-over-year, the company saw significant declines in sales, profitability, and gross margins at Arcadia and DynaEnergetics, while NobelClad's sales increased but its gross margin declined. Management's guidance signals further revenue and adjusted EBITDA contraction due to ongoing market uncertainty and weaker demand. These 10 stocks could mint the next wave of millionaires › DMC Global (NASDAQ:BOOM), a diversified manufacturing holding company with businesses in building products, energy, and industrial sectors, reported its results for the second quarter of fiscal 2025 on August 5, 2025. The most important takeaway from this release was the company's ability to outperform consensus estimates for both GAAP revenue and non-GAAP EPS, despite ongoing end-market weakness. DMC Global posted non-GAAP earnings per share of $0.12, surpassing analyst expectations of $0.02. Revenue (GAAP) reached $155.5 million, ahead of the estimated $151.4 million. Although results topped muted expectations, the quarter saw broad declines compared to the same period last year, with drops in revenue, adjusted EBITDA (non-GAAP), and net income. Overall, the period showed prudent cost management, but continued headwinds in construction, energy, and industrial markets weighed on the business. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Company Overview and Business Priorities DMC Global operates through three main business segments: Arcadia Products, which produces building components for the construction sector; DynaEnergetics, which makes perforating systems for the energy industry; and NobelClad, a manufacturer of composite metals used in chemical processing and industrial applications. The company's diversified approach allows it to engage in industries with differing growth cycles and risk profiles. In recent periods, DMC Global has focused on aligning operations with prevailing market realities. For Arcadia, this meant shifting attention from a shrinking high-end residential market to more stable commercial construction. DynaEnergetics has pursued product innovation and cost reduction in response to variable demand in U.S. oil and gas, while NobelClad has concentrated on maintaining order flow amid global trade policy uncertainty. Supply chain management and strategic decision-making remain key factors for ongoing performance. Quarter Highlights and Segment Performance DMC Global's consolidated revenue (GAAP) exceeded internal and external forecasts, but still fell 9% short compared to the prior year. Adjusted earnings per share (non-GAAP) beat consensus by $0.10. Arcadia, which makes windows and doors for commercial and high-end residential projects, posted GAAP sales of $62.0 million—a decrease of 11% from the same period last year. Segment profitability saw even steeper declines, with adjusted EBITDA attributable to DMC down 28% sequentially and 46% year-over-year. Adjusted EBITDA in Arcadia dropped to $4.0 million, down 46% year over year. Gross margins compressed from 33.2% in Q2 2024 to 26.2% in Q2 2025 for Arcadia, due to lower absorption of fixed manufacturing overhead on decreased sales. Management acted to reduce costs in the residential business and sharpened the commercial focus in response to these trends. DynaEnergetics, the manufacturer of perforating systems such as the DynaStage and DS Infinity series for oil and gas well completion, generated GAAP sales of $66.9 million, down 12% year over year. Despite lower top-line results, segment profitability improved as adjusted EBITDA rose by 3% year-over-year, reflecting cost reduction and efficiency measures. The segment's gross margin increased to 20.9% in Q2 2025 from 19.9% in Q2 2024, helped by lower material costs relative to the prior year. NobelClad, which produces composite metal plates for use in pressure vessels and other industrial infrastructure, achieved sales of $26.6 million, a 6% rise from Q2 2024. However, the order backlog declined to $37 million at the end of Q2 2025, 9.8% below the end of Q1 2025, signaling weaker forward demand due to uncertainty surrounding U.S. tariff policies. Adjusted EBITDA in this segment dropped 23% year over year, while gross margin fell sharply from 32.6% to 24.7%, attributed to less favorable project mix. Looking Ahead: Outlook and Investor Considerations For Q3 2025, DMC Global's management issued guidance for consolidated sales in the range of $142 million to $150 million, representing a sequential decline from the period just reported. Adjusted EBITDA attributable to DMC is expected between $8 million and $12 million, reflecting heightened uncertainty in end markets, especially those sensitive to macroeconomic factors and trade policy shifts. Management did not provide annual guidance for fiscal 2025 beyond the immediate quarter. The company drew attention to ongoing risks including weak demand in construction, variable activity in the oil and gas market, and unresolved tariff policies. Order visibility remains low, with particular note given to the reduction in NobelClad's backlog (from $41 million at the end of Q1 2025 to $37 million at the end of Q2 2025) and fixed cost absorption risk in Arcadia. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,039%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of August 4, 2025
Globe and Mail
7 minutes ago
- Globe and Mail
Fidelity National (FIS) Q2 Revenue Up 5%
Key Points Revenue (non-GAAP) for Q2 2025 exceeded expectations, reaching $2.60 billion compared to the $2.58 billion analyst estimate. Adjusted EPS (non-GAAP) for Q2 2025 matched estimates at $1.36, reflecting modest year-over-year growth. GAAP net loss of $470 million for Q2 2025 was driven by a non-cash tax charge related to the Worldpay sale. These 10 stocks could mint the next wave of millionaires › Fidelity National Information Services (NYSE:FIS), a major provider of technology solutions for financial institutions, reported its Q2 FY2025 earnings on August 5, 2025. The most notable update was a revenue figure of $2.60 billion (non-GAAP), beating consensus estimates. Adjusted earnings per share (EPS) came in at $1.36, in line with expectations. Despite solid revenue growth and stable operating margins, the period featured a GAAP net loss of $470 million due to a one-time, non-cash tax impact tied to the company's Worldpay asset sale. Overall, the quarter showed recurring revenue strength and operational progress but also highlighted margin pressures and increased costs tied to recent large transactions. Metric Q2 2025 Q2 2025 Estimate Q2 2024 Y/Y Change EPS (Non-GAAP) $1.36 $1.36 $1.34 1.5 % Revenue (GAAP) $2.62 billion $2.58 billion $2.49 billion 5.2 % Adjusted EBITDA (Non-GAAP) $1.04 billion $992 million 4.8 % Adjusted Free Cash Flow (Non-GAAP) $292 million $504 million (42.1 %) Net Earnings (Loss) (GAAP) ($470 million) $237 million n/m Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Business Overview and Strategic Focus Fidelity National Information Services offers software and processing solutions that power banking, payments, and capital markets around the world. Its largest businesses include banking technology platforms, payment transaction processing, and software tools for capital market clients. Its customer base includes banks, credit unions, and other financial institutions. It has focused on growing recurring revenue through internal product development and strategic transactions. Recent moves include a planned acquisition of Global Payments' Issuer Solutions, and a continued transition away from merchant solutions via the sale of Worldpay. Management believes these changes will drive long-term growth and build a more stable, predictable revenue base. The company's competitive strengths stem from its broad product suite, cloud-based technology, and long-standing client relationships. Quarter Highlights: Revenue Growth and Segment Developments Revenue for Q2 2025 reached $2.62 billion (non-GAAP), up 5.0% year-over-year and above analyst projections. This growth was fueled by recurring revenue streams, which now make up around 81% of total revenue. Adjusted EBITDA increased to $1.04 billion, reflecting a 5% rise from the prior year. The adjusted EBITDA margin remained flat at 39.8% (non-GAAP), indicating a balance between cost savings and ongoing expense pressures. In the Banking Solutions business, revenue climbed 6% year-over-year on a GAAP basis to $1.81 billion, with recurring revenue up 7%. This unit provides core banking technology, payment processing, and related software tools. However, profitability in banking was affected by higher bad debt expenses, leading to a 70 basis-point decrease in the segment's adjusted EBITDA margin to 43.6%. The Capital Market Solutions segment reported GAAP revenue growth of 6% to $765 million. This segment offers software, processing, and treasury management solutions for investment firms and financial institutions. Although sales were higher, the adjusted EBITDA margin for Capital Market Solutions dropped 53 basis points to 50.3%, due to the financial impact from integrating a recent acquisition. Both segments experienced margin contraction in adjusted EBITDA margin, raising attention to the cost side of the business even as revenue expanded. Recurring revenue growth of 6% in Q2 2025 remained a highlight. Across the company, nonrecurring revenue items, including software licenses and new client implementations, added to the revenue mix but did not fully offset margin declines. Management noted that the company returned $246 million to shareholders via share repurchases and paid $212 million in dividends during the quarter. A one-time, non-cash charge of $539 million boosted the deferred tax liability and resulted in a reported net loss (GAAP) for the quarter. This was tied to the agreement to sell the remaining interest in Worldpay, the merchant payments platform the company is moving away from. The impact does not reflect cash movement, but it does affect headline net income for the quarter. Adjusted free cash flow was $292 million, down over 40% from the prior-year Q2 2024 amount of $504 million, with management pointing to working capital timing and transaction-related expenses as causes. Product Lines and Service Developments Within its core banking software and transaction processing, the company reported increased adoption of digital banking solutions. These tools support account management and payment card issuance for financial institutions. In capital markets, treasury management solutions and derivatives processing software attracted new clients among investment firms and corporates, supporting increases in both recurring and nonrecurring revenue. Management noted continued pipeline growth across digital, core account, and payments technology, with recent wins including commercial lending software for clients in the private credit market. Strong cross-selling among product lines is expected to be enhanced by the company's planned acquisition of Issuer Solutions, which should expand credit card processing and bring additional scale to the banking segment. However, ongoing integration costs and timing-related effects on some revenue, particularly related to upfront software licensing, affected overall profitability for the period. Looking Ahead: Guidance and Key Trends Management raised its full-year 2025 outlook, targeting revenue growth of 4.8% to 5.3% and adjusted EPS growth of 10% to 11% following the period's results. For Q3 2025, projected revenue is $2.65–2.67 billion, with adjusted EPS (non-GAAP) forecast at $1.46–1.50. The company did not announce a change or pause in its shareholder return policy. The quarterly dividend for Q2 2025 was maintained, with management stating that dividends are expected to grow in line with adjusted EPS. Investors should watch for several factors in upcoming quarters: the closing and integration of the Issuer Solutions acquisition, cost management efforts to restore segment margins, the effects of higher interest expense from increased debt, and progress in converting operating gains into stronger cash flow. The complexity induced by ongoing transactions and one-time items, like the Worldpay sale, is set to continue influencing reported results and may make year-over-year comparisons difficult for some time. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,039%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. *Stock Advisor returns as of August 4, 2025
Globe and Mail
31 minutes ago
- Globe and Mail
Quantum-Si (QSI) Q2 Revenue Falls 47%
Key Points Revenue (GAAP) fell sharply below expectations, as Q2 2025 sales of $0.59 million missed analyst estimates by 46.7%. Gross margin improved to 59%, even as operating and net losses continued to mount. The company extended its cash runway into the second quarter of 2028 through a recent $50 million capital raise. These 10 stocks could mint the next wave of millionaires › Quantum-Si (NASDAQ:QSI), a developer of next-generation protein sequencing technology, reported its Q2 2025 earnings on August 5, 2025. The most significant news was a steep revenue shortfall, as GAAP sales came in at $0.59 million compared to analyst estimates of $1.11 million—a miss of nearly 46.7%. Earnings per share (EPS, GAAP) registered at $(0.16), in line with last year's second quarter. Despite this, the period brought gross margin gains and ongoing investment in product innovation. The overall results highlight continued struggles with commercial traction, particularly in U.S. academic markets, while the company maintains a strong cash position after a direct offering. Source: Analyst estimates for the quarter provided by FactSet. About Quantum-Si: Business overview and recent focus Quantum-Si is a protein sequencing technology company focused on research applications. Its goal is to make protein analysis more scalable, precise, and cost-effective, using single-molecule sequencing at the amino acid level. The firm's main platform aims to improve upon traditional tools like mass spectrometry, which can be complex and expensive. In recent quarters, Quantum-Si has focused on growing its commercial footprint through its Platinum and Platinum Pro instruments, while maintaining a pipeline of innovation. The company is actively pursuing the launch of its Proteus platform, an advanced sequencing product aimed to enhance output and automation. Key success factors include the ability to turn innovation into real revenue, expanding into non-U.S. and non-academic customer segments, and closely managing costs in the face of persistent net losses. Quarterly highlights: Financial and operational review GAAP revenue for the second quarter came in well below consensus estimates. Sales (GAAP) totaled $0.59 million. GAAP revenue declined 29.8% sequentially compared to Q1 2025. U.S. academic institutions comprise roughly 20% of account placements—a segment hit hardest by these constraints, based on company disclosures from Q1 2025. International business provided some cushioning, with about 60% of the installed base now outside the United States. The company expanded its international distributor network to 23 partners, up from 18 as of Q1 2025. Management has largely completed that expansion, shifting attention to peer-to-peer academic engagement and the launch of 'expanded instrument acquisition options' to help laboratories acquire equipment amid tighter capital budgets. Gross margin (GAAP) improved to 59%, up from 57% in the prior year quarter. This metric, which represents gross profit as a percentage of sales (GAAP), can be volatile for early-stage companies like Quantum-Si because the mix of instrument and consumable sales impacts the ratio. Management signaled that gross margin may fluctuate in the near term due to product and sales mix, as noted this quarter. Despite some operational discipline, operating costs remain high. Adjusted total operating expenses were $23.8 million, down approximately 2.5% from last year, but GAAP net loss deepened to $28.8 million, up from $23.1 million in Q2 2024. A legal settlement charge of $3.4 million pushed costs higher. Adjusted EBITDA, a measure of operating performance that strips out some non-cash or one-time items, was negative $22.2 million. The company's accumulated deficit (GAAP) increased to $644.7 million as of June 30, 2025. From a product perspective, Quantum-Si continues to invest in innovation. The Proteus platform—a next-generation sequencing system—remains scheduled for a prototype by late 2025, with commercial launch in the second half of 2026. Alongside Proteus, the Version 4 Sequencing Kit (a consumable kit that enables protein analysis) is expected to launch in Q3 2025, with a new Version 3 Library Preparation Kit expected late in the year. Library prep kits help users prepare protein samples for analysis and are important for expanding the platform's potential uses. To support market awareness, the company has increased its academic outreach via webinars and user groups. This strategy is designed to seed adoption and generate scientific publications that could drive demand. The company reported some encouraging trends, including recurring consumable purchases from existing customers and further validation of its core technology's utility beyond protein sequencing, such as post-translational modification studies. Quantum-Si's product revenue dominates sales, making up nearly all the reported figure, with service revenue a minor contributor. The company's intellectual property portfolio—which includes nearly 400 issued patents and close to 600 pending—serves as a competitive moat, and management reports prudent allocation of research and development resources to maintain its technical lead while watching cash use closely. One-time costs this quarter included the legal settlement mentioned above and $0.19 million in restructuring expenses. The firm raised an additional $50 million after the quarter through a direct stock offering, which, along with existing balances, should fund operations into the second quarter of 2028—offering breathing room but not eliminating the need to eventually ramp sales and reduce cash burn. Forward outlook and what to watch Management did not provide explicit revenue or profit guidance for the coming quarter or year, citing ongoing uncertainty, particularly as NIH funding delays persist and major revenue streams remain unpredictable. Instead, the focus remains on meeting operating expense and cash use targets for fiscal 2025: adjusted operating expenses of $103 million or less and total cash usage of $95 million or less. Looking ahead, key issues for investors will be the pace of commercial adoption outside U.S. academic markets, recurring consumable sales that signal instrument utilization, and progress toward the major product launches that underpin future growth. The updated cash runway relieves imminent financial risk, but sustained losses will require a clear path to sales growth over the next two years. QSI does not currently pay a dividend. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,039%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of August 4, 2025
